Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Med Mycol ; 49 Suppl 1: S96-S100, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21254964

ABSTRACT

We discuss in this work the role of Aspergillus biofilms in the clinical setting by reviewing the most recent findings on this topic. Aspergillus fumigatus can produce in vitro an extracellular hydrophobic matrix with typical biofilm characteristics under all static conditions tested, i.e., agar media, polystyrene and bronchial epithelial cells. Under static conditions the mycelial growth is greater than in shaken, submerged conditions. The extracellular matrix (ECM) is composed of galactomannan, α-1,3-glucans, monosaccharides and polyols, melanin and proteins including major antigens and hydrophobins. Typical biofilm structures were observed in the aspergillomas from two patients and in a murine model of invasive pulmonary aspergillosis. The results indicate that α-1,3-glucans plays a predominant role in the agglutination of the hyphae together in aerial conditions, and that nutrient starvation was responsible for mycelial death in aspergilloma. Melanin was produced during the infection, suggesting that this pigment is necessary for lung tissue invasion. All antifungal drugs are significantly less effective when A. fumigatus is grown under biofilm vs. planktonic conditions. Chronic persistence of a unique genotype of A. fumigatus in the respiratory tract of CF-patients and the presence of an ECM in vivo may have some therapeutical application for aspergillosis. The most appropriate antifungal drug should not be selected only on the basis of its efficiency to kill in vitro grown fungal cells, but also on its ability to penetrate the ECM.


Subject(s)
Aspergillosis/microbiology , Aspergillus fumigatus/physiology , Biofilms/growth & development , Animals , Antifungal Agents/pharmacology , Aspergillosis/drug therapy , Aspergillus fumigatus/drug effects , Aspergillus fumigatus/pathogenicity , Biofilms/drug effects , Bronchi/cytology , Bronchi/microbiology , Cystic Fibrosis/drug therapy , Cystic Fibrosis/microbiology , Drug Resistance, Fungal , Epithelial Cells/drug effects , Epithelial Cells/microbiology , Extracellular Matrix/metabolism , Extracellular Matrix/ultrastructure , Humans , Mice , Microbial Sensitivity Tests , Respiratory Tract Infections/drug therapy , Respiratory Tract Infections/microbiology
2.
Expert Rev Anti Infect Ther ; 8(8): 957-64, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20695750

ABSTRACT

A defective mucociliary clearance facilitates colonization with bacteria and fungal spores in cystic fibrosis patients. Yeasts and molds are cultured from the cystic fibrosis respiratory tract and often their clinical relevance is unknown. Candida spp. are the most commonly isolated yeasts, whereas Aspergillus spp., Scedosporium apiospermum, as well as Exophiala dermatitidis in some countries, are the most frequent molds recovered from respiratory specimens. Molecular biotyping studies have revealed that some fungal genotypes are capable of chronically colonizing the airways. Persistent Aspergillus fumigatus infection is associated with an increased risk of pulmonary exacerbations requiring hospitalization. The prevalence of non-Aspergillus molds may be underestimated due to overgrowth of Pseudomonas and Aspergillus spp. on routine media. Allergic bronchopulmonary aspergillosis is usually treated by oral steroids and an antifungal azole drug. Interactions with the co-medication have to be considered. A small number of antifungal pharmacokinetic studies indicate a high inter-subject variability for itraconazole, voriconazole and posaconazole, and therefore therapeutic drug monitoring is recommended.


Subject(s)
Antifungal Agents/therapeutic use , Cystic Fibrosis/complications , Fungi/classification , Mycoses/drug therapy , Mycoses/microbiology , Respiratory Tract Infections/drug therapy , Adolescent , Adult , Aspergillus/isolation & purification , Candida/isolation & purification , Child , Child, Preschool , Cystic Fibrosis/microbiology , Exophiala/isolation & purification , Fungi/pathogenicity , Humans , Mycoses/epidemiology , Prevalence , Respiratory Tract Infections/microbiology , Sputum/microbiology , Young Adult
3.
Proteomics ; 10(17): 3097-107, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20645385

ABSTRACT

The opportunistic pathogenic mold Aspergillus fumigatus is an increasing cause of morbidity and mortality in immunocompromised and in part immunocompetent patients. A. fumigatus can grow in multicellular communities by the formation of a hyphal network encased in an extracellular matrix. Here, we describe the proteome and transcriptome of planktonic- and biofilm-grown A. fumigatus mycelium after 24 and 48 h. A biofilm- and time-dependent regulation of many proteins and genes of the primary metabolism indicates a developmental stage of the young biofilm at 24 h, which demands energy. At a matured biofilm phase, metabolic activity seems to be reduced. However, genes, which code for hydrophobins, and proteins involved in the biosynthesis of secondary metabolites were significantly upregulated. In particular, proteins of the gliotoxin secondary metabolite gene cluster were induced in biofilm cultures. This was confirmed by real-time PCR and by detection of this immunologically active mycotoxin in culture supernatants using HPLC analysis. The enhanced production of gliotoxin by in vitro formed biofilms reported here may also play a significant role under in vivo conditions. It may confer A. fumigatus protection from the host immune system and also enable its survival and persistence in chronic lung infections such as aspergilloma.


Subject(s)
Aspergillus fumigatus/physiology , Biofilms/growth & development , Gliotoxin/biosynthesis , Proteomics/methods , Analysis of Variance , Aspergillus fumigatus/genetics , Aspergillus fumigatus/metabolism , Cluster Analysis , Electrophoresis, Gel, Two-Dimensional , Fungal Proteins/biosynthesis , Fungal Proteins/genetics , Gene Expression Profiling/methods , Mycelium/metabolism , Oligonucleotide Array Sequence Analysis , Reverse Transcriptase Polymerase Chain Reaction
4.
FEMS Immunol Med Microbiol ; 60(1): 74-7, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20626764

ABSTRACT

The possible involvement of Toll-like receptors (TLRs) 1, 2, 4 and 9 in the interaction of antifungal drugs with polymorphonuclear neutrophils (PMNs) in response to Aspergillus fumigatus and Candida albicans as stimuli was investigated. Caspofungin revealed the broadest capacity to enable C. albicans and A. fumigatus to stimulate TLR upregulation, TLR 2 by A. fumigatus and TLRs 4, 9 by C. albicans. Conventional amphotericin B (cAMB) stimulated only A. fumigatus to induce TLRs 2 and 4 upregulation; voriconazole stimulated A. fumigatus and fluconazole C. albicans to induce TLR 9 upregulation. For cAMB, only TLR 9 was upregulated by A. fumigatus, whereas in the case of voriconazole, TLRs 2, 4, 9 were upregulated. Caspofungin revealed the broadest capacity: C. albicans was stimulated to upregulate TLRs at least at one of the concentrations, and A. fumigatus was stimulated to upregulate TLRs 2, 4. TLR 9 was upregulated two to three fold by all antifungal drugs on protein, except for fluconazole at the RNA level. Candida albicans preincubated with caspofungin has additional effects on CD11b expression and IL8 chemotaxis in CpG-DNA-stimulated PMNs. These results indicate a relevant upregulation with a functional relevance of TLR 9 in the presence of C. albicans strains preincubated with caspofungin at three concentrations.


Subject(s)
Aspergillus fumigatus/immunology , Candida albicans/immunology , Echinocandins/metabolism , Granulocyte-Macrophage Colony-Stimulating Factor/immunology , Immunologic Factors/metabolism , Neutrophils/immunology , Toll-Like Receptors/biosynthesis , Amphotericin B/metabolism , Antifungal Agents/metabolism , CD11b Antigen/biosynthesis , Caspofungin , Cells, Cultured , Gene Expression , Gene Expression Profiling , Humans , Interleukin-8/metabolism , Lipopeptides , Neutrophils/drug effects , Pyrimidines/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Toll-Like Receptors/immunology , Triazoles/metabolism , Up-Regulation , Voriconazole
5.
FEMS Yeast Res ; 10(4): 492-5, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20345899

ABSTRACT

The aim of this study was to test whether a Candida albicans biofilm can be eradicated by liposomal amphotericin B (LAMB) at the minimal inhibitory concentration in a novel catheter continuous flow model. After 24-h biofilm formation and a 24-h treatment with LAMB, the growth of the hyphal network was reduced to 20% in comparison with the untreated control, whereas fluconazole and caspofungin remained at an intermediate phase (50%). After 24-h biofilm formation and a 24-h treatment with LAMB, 20% of the surface was covered in biofilm and LAMB caused an uneven surface. For caspofungin and fluconazole, the surface covering was 80%. The extracellular matrix (ECM) of the infected, but untreated catheters had a thickness of 5-20 microm at 24 h and 10-150 microm at 48 h. After 24-h biofilm formation and a 24-h treatment with LAMB, the ECM was virtually cleared with 0 microm ECM. After 24-h biofilm formation and a 24-h treatment with fluconazole, the ECM thickness was comparable to the infected, but untreated catheter at 24 h with 10-25 microm; with caspofungin, the ECM thickness was comparable to the infected, but untreated catheter at 48 h with 10-130 microm. Comparing the blastospores, pseudohyphae and ECM, 0.5 microg mL(-1) LAMB could eradicate Candida biofilm, whereas fluconazole and caspofungin were less effective.


Subject(s)
Amphotericin B/pharmacology , Antifungal Agents/pharmacology , Biofilms/drug effects , Candida albicans/drug effects , Catheter-Related Infections/drug therapy , Catheters, Indwelling/microbiology , Biofilms/growth & development , Candida albicans/growth & development , Caspofungin , Echinocandins/pharmacology , Extracellular Matrix/metabolism , Fluconazole/pharmacology , Lipopeptides , Microbial Viability/drug effects , Microscopy, Confocal , Microscopy, Electron, Scanning , Time Factors
6.
Med Mycol ; 48(1): 56-63, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19184771

ABSTRACT

It is still controversial as to whether Candida spp. are transient or persistent colonizers of the respiratory tract of cystic fibrosis (CF) patients. We conducted a prospective study of 56 CF patients over a 30 month period to assess the distribution and persistence of different Candida spp. In vitro antifungal susceptibility testing was performed and the C. albicans isolates were typed with CARE-2 hybridization and other Candida spp. by RAPD-PCR for persistence and transmission. We found that the mean persistence of the most frequent Candida spp. was >or= 9 months. In patients from whom more than 10 isolates were recovered, we noted that at least 30% were genetically related and transmission of C. albicans in siblings was observed. The majority of all isolates were susceptible to all antifungals tested. We concluded that there was long-term persistence of Candida in the respiratory tract of CF patients and that transmission between siblings may be one possible means of acquisition. Whether long-term colonization with Candida strains can contribute to the chronic infection and inflammation in the CF lung requires further investigation.


Subject(s)
Candida/isolation & purification , Candidiasis/microbiology , Cystic Fibrosis/complications , Respiratory System/microbiology , Adolescent , Adult , Candida/classification , Candida/genetics , Child , Child, Preschool , Cluster Analysis , DNA Fingerprinting , Female , Genotype , Humans , Infant , Male , Microbial Sensitivity Tests , Mycological Typing Techniques , Nucleic Acid Hybridization , Prospective Studies , Random Amplified Polymorphic DNA Technique , Young Adult
7.
J Cyst Fibros ; 8(2): 110-4, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19041282

ABSTRACT

Aspergillus fumigatus is a chronic colonizer of the respiratory tract of patients with cystic fibrosis (CF). A total of 204 A. fumigatus isolates from 36 CF patients from three different medical centers, collected over a period of four months till 9.5 years, were genotyped using the short tandem repeat panel for A. fumigatus (STRAf assay). Four different colonization patterns were observed. Colonization patterns with only unique genotypes were found in 36% of the patients. In contrast 17% of the patients were chronically colonized with a single genotype. The remaining patients showed a predominant genotype or genotypes that succeed each other. In this collection no relation was found between colonization patterns and allergic bronchopulmonary aspergillosis.


Subject(s)
Aspergillus fumigatus/genetics , Aspergillus fumigatus/isolation & purification , Cystic Fibrosis/microbiology , Genotype , Respiratory System/microbiology , Child , Child, Preschool , Humans , Infant , Mycological Typing Techniques , Sputum/microbiology
8.
Antimicrob Agents Chemother ; 52(11): 4130-6, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18710910

ABSTRACT

Aspergillus fumigatus is a leading cause of death in immunocompromised patients and a frequent colonizer of the respiratory tracts of asthma and cystic fibrosis (CF) patients. Biofilms enable bacteria and yeasts to persist in infections and can contribute to antimicrobial resistance. We investigated the ability of A. fumigatus to form biofilms on polystyrene (PS) and human bronchial epithelial (HBE) and CF bronchial epithelial (CFBE) cells. We developed a novel in vitro coculture model of A. fumigatus biofilm formation on HBE and CFBE cells. Biofilm formation was documented by dry weight, scanning electron microscopy (SEM), and confocal scanning laser microscopy (CSLM). The in vitro antifungal activities of seven antifungal drugs were tested by comparing planktonic and sessile A. fumigatus strains. A. fumigatus formed an extracellular matrix on PS and HBE and CFBE cells as evidenced by increased dry weight, SEM, and CSLM. These biofilms exhibited decreased antifungal drug susceptibility and were adherent to the epithelial cells, with fungi remaining viable throughout 3 days. These observations might have implications for treatment of A. fumigatus colonization in chronic lung diseases and for its potential impact on airway inflammation, damage, and infection.


Subject(s)
Antifungal Agents/pharmacology , Aspergillus fumigatus/drug effects , Aspergillus fumigatus/physiology , Biofilms/drug effects , Bronchi/drug effects , Bronchi/microbiology , Aspergillosis/drug therapy , Aspergillosis/microbiology , Aspergillus fumigatus/pathogenicity , Biofilms/growth & development , Bronchi/cytology , Cells, Cultured , Cystic Fibrosis/drug therapy , Cystic Fibrosis/microbiology , Drug Resistance, Fungal , Epithelial Cells/drug effects , Epithelial Cells/microbiology , Humans , Microbial Sensitivity Tests , Microscopy, Confocal , Microscopy, Electron, Scanning , Respiratory Tract Infections/drug therapy , Respiratory Tract Infections/microbiology
9.
Invest Radiol ; 42(10): 715-25, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17984769

ABSTRACT

OBJECTIVES: As pulmonary complications are life limiting in patients with cystic fibrosis (CF), repeated chest imaging [chest x-ray, computed tomography (CT)] is needed for follow up. With the continuously rising life expectancy of CF patients, magnetic resonance imaging (MRI) as a radiation-free imaging modality might become more and more attractive. The goal of this study was to prospectively assess the value of MRI for evaluation of morphologic pulmonary CF-changes in comparison to established imaging modalities. MATERIALS AND METHODS: Thirty-one CF patients (19 female, 12 male; mean age 16.7 years) with stable lung disease were examined by MRI: HASTE, coronal/transversal (TR/TE/alpha/TA: infinite/28 ms/180 degrees /18 s), multi-detector computed tomography (MDCT) (30 patients): 120 kV, dose modulated mAs, and chest x-ray (21 patients). Image evaluation: random order, 4 chest radiologists in consensus; chest x-ray: modified Chrispin-Norman score; CT and MRI: modified Helbich score. The maximal attainable score for chest x-ray was 34, for MRI and CT 25. Median scores, Pearson correlation coefficients, Bland-Altman plots, and concordance of MRI to CT on a lobar and segmental basis were calculated. RESULTS: The median MRI and MDCT scores were 13 (min 3, max 20) respectively 13.5 (min 0, max 20). The median chest x-ray score was 14 (min 5, max 32). Pearson correlation coefficients: MRI/CT = 0.80, P < 0.0001; MRI/chest x-ray = 0.63, P < 0.0018; chest x-ray/CT = 0.75, P < 0.0001. The median lobe related concordance was 80% for bronchiectasis, 77% for mucus plugging, 93%, for sacculation/abscesses, and 100% for collapse/consolidation. CONCLUSIONS: Morphologic MRI of the lung in CF patients demonstrates comparable results to MDCT and chest x-ray. Because radiation exposure is an issue in CF patients, MRI might have the ability to be used as an appropriate alternative method for pulmonary imaging.


Subject(s)
Cystic Fibrosis/pathology , Lung Diseases/pathology , Lung/pathology , Magnetic Resonance Imaging/instrumentation , Adolescent , Cystic Fibrosis/diagnostic imaging , Disease Progression , Female , Health Status Indicators , Humans , Lung/diagnostic imaging , Lung Diseases/diagnostic imaging , Male , Prospective Studies , Radiography , Tomography, Emission-Computed/instrumentation
10.
Antimicrob Agents Chemother ; 51(8): 3014-6, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17548494

ABSTRACT

Cross-resistance among Candida albicans isolates from the oropharynges of human immunodeficiency virus-infected patients (n = 16) and environmental yeast strains of various species (n = 54) to medical and agricultural azole drugs was observed. Precautions against the unnecessary widespread use of azoles in the environment and human medicine are strongly recommended to prevent patients from acquiring azole-resistant yeasts.


Subject(s)
Antifungal Agents/pharmacology , Azoles/pharmacology , Candida albicans/drug effects , Drug Resistance, Fungal , Fungicides, Industrial/pharmacology , Oropharynx/microbiology , Vitis/microbiology , AIDS-Related Opportunistic Infections/microbiology , Candida albicans/classification , Candida albicans/isolation & purification , Candidiasis, Oral/drug therapy , Candidiasis, Oral/microbiology , Environmental Microbiology , Germany , HIV Infections/complications , HIV-1 , Humans , Microbial Sensitivity Tests
11.
Eur Radiol ; 17(3): 716-24, 2007 Mar.
Article in English | MEDLINE | ID: mdl-16941092

ABSTRACT

Cystic fibrosis (CF) is the most frequent inherited disorder leading to premature death in the Caucasian population. As life expectancy is limited by pulmonary complications, repeated imaging [chest X-ray, multislice high-resolution computed tomography (MS-HRCT)] is required in the follow-up. Magnetic resonance imaging (MRI) of the lung parenchyma is a promising new diagnostic tool. Its value for imaging lung changes caused by CF compared with CT is demonstrated. MRI performs well when compared with CT, which serves as the gold standard. Its lack in spatial resolution is obvious, but advantages in contrast and functional assessment compensate for this limitation. Thus, MRI is a reasonable alternative for imaging the CF lung and should be introduced as a radiation-free modality for follow-up studies in CF patients. For further evaluation of the impact of MRI, systematic studies comparing MRI and conventional imaging modalities are necessary. Furthermore, the value of the additional functional MRI (fMRI) information has to be studied, and a scoring system for the morphological and functional aspect of MRI has to be established.


Subject(s)
Bronchi/pathology , Cystic Fibrosis/diagnostic imaging , Cystic Fibrosis/pathology , Magnetic Resonance Imaging , Mucus/metabolism , Adolescent , Adult , Bronchography , Child , Female , Humans , Male , Tomography, X-Ray Computed
12.
Int J Antimicrob Agents ; 28(6): 568-73, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17101265

ABSTRACT

Long-term inserted and surgically implanted catheters can be colonised by Candida spp. Candida biofilms in vitro are often resistant to antifungal agents. The aim of this study was to investigate the in vitro activity of micafungin (MFG) against six Candida spp. biofilms on polystyrene (PS) and central venous catheter (CVC) sections. Safranin staining and differential interference contrast microscopy were used to demonstrate biofilm production. MFG activity was determined by the reduction in metabolic activity (%RMA) by tetrazolium reduction assay on both substrates. In vitro, Candida albicans, Candida parapsilosis, Candida glabrata, Candida tropicalis, Candida dubliniensis and Candida kefyr produced mature biofilms on PS and CVC sections. MFG was active against C. kefyr (0.5 microg/mL) and C. glabrata (<0.5 microg/mL) on PS. However, MFG displayed resistance (>16 microg/mL) against C. albicans, C. dubliniensis,C. tropicalis and C. parapsilosis. On CVC disks, MFG was active against C. glabrata (1 microg/mL) as well as C. parapsilosis and C. albicans (<0.5 microg/mL). MFG was resistant (>16 microg/mL) against C. dubliniensis, C. tropicalis and C. kefyr. MFG was active in vitro against all six Candida spp. on both substrates. However, MFG could not reduce the metabolic activity completely even at the highest concentration.


Subject(s)
Antifungal Agents/pharmacology , Biofilms/drug effects , Candida/drug effects , Catheterization, Central Venous , Catheters, Indwelling/microbiology , Infant, Premature, Diseases/microbiology , Lipoproteins/pharmacology , Peptides, Cyclic/pharmacology , Polystyrenes , AIDS-Related Opportunistic Infections/microbiology , Adult , Biofilms/growth & development , Candida/classification , Candida/growth & development , Candida/isolation & purification , Candidiasis/microbiology , Child , Echinocandins , Humans , Infant, Newborn , Lipopeptides , Micafungin , Microbial Sensitivity Tests/methods , Microscopy, Interference , Phenazines , Staining and Labeling/methods , Tetrazolium Salts
13.
Eur Radiol ; 16(10): 2147-52, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16673092

ABSTRACT

This paper is a feasibility study of magnetic resonance imaging (MRI) of lung perfusion in children with cystic fibrosis (CF) using contrast-enhanced 3D MRI. Correlation assessment of perfusion changes with structural abnormalities. Eleven CF patients (9 f, 2 m; median age 16 years) were examined at 1.5 T. Morphology: HASTE coronal, transversal (TR/TE/alpha/ST: 600 ms/28 ms/180 degrees /6 mm), breath-hold 18 s. Perfusion: Time-resolved 3D GRE pulse sequence (FLASH, TE/TR/alpha: 0.8/1.9 ms/40 degrees ), parallel imaging (GRAPPA, PAT 2). Twenty-five data sets were acquired after intravenous injection of 0.1 mmol/kg body weight of gadodiamide, 3-5 ml/s. A total of 198 lung segments were analyzed by two radiologists in consensus and scored for morphological and perfusion changes. Statistical analysis was performed by Mantel-Haenszel chi-square test. Results showed that perfusion defects were observed in all patients and present in 80% of upper, and 39% of lower lobes. Normal lung parenchyma showed homogeneous perfusion (86%, P<0.0001). Severe morphological changes led to perfusion defects (97%, P<0.0001). Segments with moderate morphological changes showed normal (53%) or impaired perfusion (47%). In conclusion, pulmonary perfusion is easy to judge in segments with normal parenchyma or severe changes. In moderately damaged segments, MRI of lung perfusion may help to better assess actual functional impairment. Contrast-enhanced 3D MRI of lung perfusion has the potential for early vascular functional assessment and therapy control in CF patients.


Subject(s)
Cystic Fibrosis/physiopathology , Imaging, Three-Dimensional , Lung/physiopathology , Magnetic Resonance Imaging/methods , Adolescent , Adult , Chi-Square Distribution , Child , Contrast Media/administration & dosage , Feasibility Studies , Female , Gadolinium DTPA/administration & dosage , Humans , Lung/blood supply , Male
14.
Antimicrob Agents Chemother ; 49(12): 5157-9, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16304192

ABSTRACT

Effects of voriconazole combined with micafungin against 101 isolates of Candida spp. and 100 isolates of filamentous fungi have been evaluated by in vitro checkerboard analysis. The combination was indifferent for 97% of the Candida isolates and synergistic for 64% of the filamentous fungi (79% for Aspergillus fumigatus).


Subject(s)
Antifungal Agents/pharmacology , Aspergillus/drug effects , Candida/drug effects , Fusarium/drug effects , Lipoproteins/pharmacology , Peptides, Cyclic/pharmacology , Pyrimidines/pharmacology , Scedosporium/drug effects , Triazoles/pharmacology , Drug Synergism , Drug Therapy, Combination , Echinocandins , Lipopeptides , Micafungin , Microbial Sensitivity Tests , Voriconazole
15.
J Antimicrob Chemother ; 55(6): 1016-9, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15883179

ABSTRACT

OBJECTIVES: The effect of different media and composition on the in vitro activity of posaconazole, caspofungin and voriconazole against 59 zygomycetes species was determined. METHODS: The media tested were RPMI 1640 medium with and without 2% glucose, antibiotic medium 3 (AM3) with and without 2% glucose, and high resolution (HR) medium. RESULTS: Posaconazole was significantly more active than caspofungin and voriconazole, both in RPMI 1640 medium with 2% glucose and in HR medium. Adding glucose improved the determination of end points, but had only minor influence on the MICs. MICs evaluated in AM3 were lower than in RPMI 1640 medium or HR medium. CONCLUSIONS: The in vivo effect of posaconazole in zygomycosis needs further evaluation.


Subject(s)
Antifungal Agents/pharmacology , Mucorales/drug effects , Peptides, Cyclic/pharmacology , Pyrimidines/pharmacology , Triazoles/pharmacology , Absidia/drug effects , Absidia/growth & development , Caspofungin , Culture Media , Cunninghamella/drug effects , Cunninghamella/growth & development , Echinocandins , Lipopeptides , Microbial Sensitivity Tests , Mucor/drug effects , Mucor/growth & development , Mucorales/growth & development , Rhizopus/drug effects , Rhizopus/growth & development , Voriconazole
16.
Eur Radiol ; 15(8): 1575-80, 2005 Aug.
Article in English | MEDLINE | ID: mdl-15761712

ABSTRACT

Cystic fibrosis (CF) leads to disabling lung disease and pulmonary hypertension (PH). The goal of this study was to assess the hemodynamics in the systemic and pulmonary arterial circulation of patients with CF using MRI. Ten patients with CF and 15 healthy volunteers were examined (1.5-T MRI). Phase-contrast flow measurements were assessed in the ascending aorta, pulmonary trunc, and the left and right pulmonary arteries (PA), resulting in the following parameters: peak velocity (PV) (centimeters per second) velocity rise gradient (VRG), time to PV (milliseconds), and the average area (centimeters squared). The blood flow ratio between the right and left lungs and the bronchosystemic shunt were calculated. For the ascending aorta and pulmonary trunc no parameter was significantly different between both populations. In the right PA a significantly lower PV (p=0.001) and VRG (p=0.02) was found. In the left PA there was a significantly (p=0.007) lower PV but no significant (p=0.07) difference between the VRG. The areas of the right (p=0.08) and left (p=0.5) PA were not significantly enlarged. For the volunteers a linear increase of PV in both PA was found with age, while it decreased in patients with CF. The blood flow distribution (right/left lung) showed no significant (p=0.7) difference between the groups. There was a significantly (p<0.001) higher bronchosystemic shunt volume in patients with CF (1.3 l/min) than in volunteers (0.1 l/min). Magnetic resonance based flow measurements in the right and left PA showed first indications for early development of PH. The significant increase in bronchosystemic shunt volume might be indicative fo the extent of parenchymal changes.


Subject(s)
Cystic Fibrosis/physiopathology , Hemodynamics/physiology , Magnetic Resonance Imaging , Pulmonary Circulation/physiology , Adult , Cystic Fibrosis/pathology , Female , Humans , Hypertension, Pulmonary/pathology , Hypertension, Pulmonary/physiopathology , Male
17.
Blood ; 105(6): 2549-56, 2005 Mar 15.
Article in English | MEDLINE | ID: mdl-15546957

ABSTRACT

The balance of arginine metabolism via nitric oxide synthase (NOS) or arginase is an important determinant of the inflammatory response of murine macrophages and dendritic cells. Here we analyzed the expression of the isoform arginase I in human myeloid cells. Using healthy donors and patients with arginase I deficiency, we found that in human leukocytes arginase I is constitutively expressed only in granulocytes and is not modulated by a variety of proinflammatory and anti-inflammatory stimuli in vitro. We demonstrate that arginase I is localized in azurophil granules of neutrophils and constitutes a novel antimicrobial effector pathway, likely through arginine depletion in the phagolysosome. Our findings demonstrate important differences between murine and human leukocytes with respect to regulation and function of arginine metabolism via arginase.


Subject(s)
Antifungal Agents/metabolism , Arginase/metabolism , Gene Expression Regulation, Enzymologic/physiology , Neutrophils/enzymology , Nitric Oxide Synthase/metabolism , Secretory Vesicles/enzymology , Animals , Arginine , Humans , Hyperargininemia , Isoenzymes/metabolism , Macrophages/enzymology , Macrophages/ultrastructure , Mice , Microscopy, Electron, Transmission , Neutrophils/ultrastructure , Nitric Oxide Synthase/deficiency , Phagosomes/enzymology , Phagosomes/ultrastructure , Secretory Vesicles/ultrastructure , Species Specificity
18.
Mycoses ; 47(7): 319-25, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15310338

ABSTRACT

The in vitro interactions of caspofungin (CSP) with terbinafine (TRB) and ravuconazole (RVC) with 5-fluorocytosine (5-FC) were tested against 82 clinical and environmental isolates of Cryptococcus neoformans from China. The interaction of CSP with TRB proved synergistic against those isolates with a CSP MIC < or =2 microg ml-1 (5% of the isolates), additive against 42% of the isolates and indifferent against 53%. The effects of RVC with 5-FC were synergistic, additive or indifferent against 8%, 26% and 67% of the isolates, respectively. No antagonistic effects were found among any of the drugs. The combinations of CSP with TRB and RVC with 5-FC may display beneficial effects in a strain-dependent manner, while in no case showed antagonistic effects. These data might be of use to design safer and more efficient treatments for patients with cryptococcosis and warrant further evaluation.


Subject(s)
Antifungal Agents/pharmacology , Columbidae/microbiology , Cryptococcosis/microbiology , Cryptococcus neoformans/drug effects , Drug Interactions , Feces/microbiology , Peptides, Cyclic , Animals , Caspofungin , China , Cryptococcus neoformans/isolation & purification , Echinocandins , Flucytosine/pharmacology , Humans , Lipopeptides , Microbial Sensitivity Tests , Naphthalenes/pharmacology , Peptides/pharmacology , Terbinafine , Thiazoles/pharmacology , Triazoles/pharmacology
19.
Antimicrob Agents Chemother ; 48(7): 2730-2, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15215137

ABSTRACT

We evaluated the effect of the combination of micafungin and polymorphonuclear leukocytes (PMN) against hyphae of Candida albicans and Candida dubliniensis. Micafungin enhanced the PMN oxidative burst dose dependently. The combination was synergistic (C. albicans) or additive (C. dubliniensis); when PMN were pretreated with granulocyte-macrophage colony-stimulating factor, the combination was more effective.


Subject(s)
Candida/drug effects , Hyphae/drug effects , Lipoproteins/pharmacology , Neutrophils/microbiology , Peptides, Cyclic/pharmacology , Phagocytosis/drug effects , Echinocandins , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Humans , In Vitro Techniques , Lipopeptides , Micafungin , Neutrophils/drug effects , Neutrophils/metabolism , Respiratory Burst/drug effects , Stimulation, Chemical , Superoxides/metabolism
20.
Eur J Pediatr ; 161(11): 563-74, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12424579

ABSTRACT

UNLABELLED: Invasive aspergillosis (IA) is a serious life-threatening complication in immunocompromised children. The commonest risk groups are children with acquired immunodeficiency syndrome, leukaemia, corticosteroid and other immunosuppressive therapy, chronic granulomatous disease and severe combined immunodeficiency as well as neonates. The clinical manifestations are heterogeneous and many organ systems can be involved. Diagnosis based on the clinical presentation alone is cumbersome. Innovative and sensitive laboratory test systems which detect fungal antigens or DNA in clinical specimens have been recently developed. Specific Aspergillus antibody detection using recombinant antigen technique has also been introduced. Although each individual technique has drawbacks, the combined use of culture with antigen and antibody ELISA as well as PCR should result in an earlier and more definitive diagnosis of IA in children presenting with clinical and/or radiological signs of aspergillosis. In high risk children these methods are valuable for serial screening and early detection of Aspergillus infection. The implementation of accurate diagnostic criteria and standardised diagnostic flow charts in children at risk will lead to a better outcome of IA in the future. CONCLUSION: definite, well-timed early diagnosis and sufficient therapy is elementary for a successful outcome of invasive aspergillosis in immunocompromised children. To date, the diagnosis of invasive aspergillosis remains a combination of clinical presentation, radiology and microbiological tests.


Subject(s)
Aspergillosis/diagnosis , Immunocompromised Host , Aspergillosis/complications , Aspergillosis/diagnostic imaging , Aspergillosis/immunology , Child , Enzyme-Linked Immunosorbent Assay , Granulomatous Disease, Chronic/complications , HIV Infections/complications , Humans , Infant, Newborn , Infant, Premature , Lung Diseases, Fungal/diagnosis , Magnetic Resonance Angiography , Polymerase Chain Reaction , Radiography , Serologic Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...